Ron Wyden

Our bipartisan efforts on organ transplants--thank you very much, Senator Grassley--have really paid off.

In my view, that's a clear example of the perverse incentives PBMs have created that leave so many Americans fed up and outraged at the health-care system in this country.

I'm proud to say that this is a hearing with strong bipartisan interest, and Senator Crapo and I have agreed to take on this issue together.

That means looking at pharmacy benefit manager practices with a thorough eye and taking any legislative steps necessary to ensure taxpayers and patients aren't getting a raw deal.

Your bill with Senator Grassley should make it more difficult for PBMs to hide profits from regulators.

I am leading a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would crack down on PBM's opaque rebate practices.

What recommendations do you have for how and where to increase transparency throughout the prescription drug supply chain?

The Pharmacy Benefit Manager Transparency Act of 2023 would make material improvements to the transparency of the U.S. health-care system.

I am working on a bill with Senator Grassley, the Pharmacy Benefit Manager Transparency Act, which would shine a light on bad PBM practices.

Every drug should have a price that is available for all to see and creates equity.

I am going to go out and have all these town hall meetings, and I am going to hold that up.

People care a whole lot about this matter of getting mugged at the pharmacy counter.

Civica cannot get the big three PBMs to cover the drug.

Taxpayers, seniors facing a 2,000-percent markup.

The average price that PBMs charge Medicare Part D plans for the exact same drug is over $3,000.

That is why I previously cosponsored something called Creating Transparency to Have Drug Rebates Unlocked.

We want to make this a bipartisan effort in this committee.

It undermines the negotiation entirely.

The problem is that the person negotiating on behalf of the patient should not be getting paid by the other side.

Our bipartisan efforts on organ transplants--thank you very much, Senator Grassley--have really paid off.

This is more reason for the Congress and this Committee to step in and do this job and do it in a bipartisan way.

There are clearly too many jobs in the Federal government that require a security clearance.

One of the reasons is that there are too many secrets of matters that do not need to be secret.

Senator Moynihan always stood for the proposition that a big part of the job in intelligence is striking the balance between transparency and protecting sources and methods.

I think your answer is spot-on, and I would be interested in any information you have or could supply.